The Binding Activity of Human DLL3 with Anti-DLL3 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Human DLL3 (CSB-MP882142HU2d7) at 2 µg/mL can bind Anti-DLL3 recombinant antibody. The EC50 is 3.990-4.723 ng/mL.
The Binding Activity of Human DLL3 with Anti-DLL3 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Human DLL3 (CSB-MP882142HU3) at 1 µg/mL can bind Anti-DLL3 recombinant antibody. The EC50 is 6.080-7.240 ng/mL.
The Binding Activity of Human DLL3 with Anti-DLL3 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Human DLL3 (CSB-MP882142HU3d7) at 2 µg/mL can bind Anti-DLL3 recombinant antibody. The EC50 is 1.107-1.282 ng/mL.
The Binding Activity of Human DLL3 with Anti-DLL3 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Human DLL3 (CSB-MP882142HU2) at 1 µg/mL can bind Anti-DLL3 recombinant antibody. The EC50 is 6.211-7.209 ng/mL.
SHP-77 cells were stained with Human IgG1&Igkappa Isotype Control (CSB-RA011156MA1HU) (green line) and anti-DLL3 antibody (CSB-RA882142MA2HU) (2µg/1*106cells) (red line) , washed and then followed by APC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten